Review question As recommended by the World Health Organization (WHO), oseltamivir (Tamiflu) is currently used for people with influenza A. In previous pandemics, the virus was susceptible to ...

Osteoarthritis is a chronic joint disease that involves degeneration of articular cartilage. Pre-clinical data suggest that doxycycline might act as a disease-modifying agent for the treatment of ...

Review question We reviewed the evidence about the effect of any treatment for thoracic outlet syndrome (TOS). Background TOS is one of the most controversial diagnoses in medicine. The term TOS ...

Why is this review important? People with panic disorder are profoundly impacted by this condition, often experiencing challenges with work, education and social or family life. We wanted to evaluate ...

This updated Cochrane Review of reminiscence therapy (RT) for dementia was first published in 1998, and last updated in 2005. RT involves the discussion of memories and past experiences with other ...

Ispitujemo dokaze koji stoje iza pitanja koja utječu na živote ljudi, osnažujući sve da donose bolje odluke Znanstvenici, ...

Posttraumatic stress disorder (PTSD) is a prevalent and disabling disorder. Evidence that PTSD is characterised by specific psychobiological dysfunctions has contributed to a growing interest in the ...

Membrane sweeping may be effective in achieving a spontaneous onset of labour, but the evidence for this was of low certainty. When compared to expectant management, it potentially reduces the ...

Para saintis, pembuat dasar dan pembuat keputusan merujuk kepada kami untuk bukti yang boleh dipercayai. Ketahui sebab bukti ...

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas of global health: dengue prevention and neonatal mortality reduction.

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas of global health: dengue prevention and neonatal mortality reduction.

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas ...